We use your email only to reply to you.
Science partner at TCG Crossover; Howard Hughes Medical Institute investigator who directs Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program; his work on BCR-ABL led to the leukaemia drug Gleevec.
TCG Crossover